News

4/26/2009Sovicell presents a poster on their method for predicting the extent of brain penetration3/16/2009Sovicell presents a talk on optimizing CNS penetration of drugs2/8/2009Sovicell presents a new method for predicting brain availability at the LogP meeting1/22/2009Sovicell presents a talk on plasma protein binding

About Sovicell

Investor Relations

Apart from the management team shareholders in SOVICELL include:

MIG AG & CO KG Investment fund I,
Corporage Finance Holding,
Wellington Partners GmbH,
German Austrian Beteiligungs GmbH & CO KG
Global Asset Fund GmbH & CO KG.

For further information on investment opportunities at Sovicell, please contact Sven Rüger, CFO.